CareDx Inc (CDNA)
CareDx Inc Statistics
Share Statistics
CareDx Inc has 55.6M shares outstanding. The number of shares has increased by 6.42% in one year.
| Shares Outstanding | 55.6M |
| Shares Change (YoY) | 6.42% |
| Shares Change (QoQ) | 3.34% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 51.73M |
| Failed to Deliver (FTD) Shares | 2.24K |
| FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 6.05M, so 11.28% of the outstanding shares have been sold short.
| Short Interest | 6.05M |
| Short % of Shares Out | 11.28% |
| Short % of Float | 14.88% |
| Short Ratio (days to cover) | 7.8 |
Valuation Ratios
The PE ratio is 21.5 and the forward PE ratio is -845. CareDx Inc's PEG ratio is -0.17.
| PE Ratio | 21.5 |
| Forward PE | -845 |
| PS Ratio | 3.39 |
| Forward PS | 1.5 |
| PB Ratio | 2.99 |
| P/FCF Ratio | 35.8 |
| PEG Ratio | -0.17 |
Enterprise Valuation
CareDx Inc has an Enterprise Value (EV) of 1.04B.
| EV / Sales | 3.13 |
| EV / EBITDA | -30.7 |
| EV / EBIT | 27.43 |
| EV / FCF | 33.06 |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.94 |
| Quick Ratio | 3.72 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.83 |
| Debt / FCF | 0.9 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 13.89% and Return on Invested Capital is 10.09%.
| Return on Equity | 13.89% |
| Return on Assets | 10.7% |
| Return on Invested Capital | 10.09% |
| Revenue Per Employee | $518.3K |
| Profits Per Employee | $81.6K |
| Employee Count | 644 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 5.62 |
Taxes
| Income Tax | 310K |
| Effective Tax Rate | 0.59% |
Stock Price Statistics
The stock price has increased by 62.46% in the last 52 weeks. The beta is 2.27, so CareDx Inc's price volatility has been higher than the market average.
| Beta | 2.27 |
| 52-Week Price Change | 62.46% |
| 50-Day Moving Average | 18.87 |
| 200-Day Moving Average | 23.41 |
| Relative Strength Index (RSI) | 31.64 |
| Average Volume (20 Days) | 921.49K |
Income Statement
In the last 12 months, CareDx Inc had revenue of 333.79M and earned 52.55M in profits. Earnings per share was 1.
| Revenue | 333.79M |
| Gross Profit | 224.16M |
| Operating Income | 40.77M |
| Net Income | 52.55M |
| EBITDA | -33.99M |
| EBIT | -53.75M |
| Earnings Per Share (EPS) | 1 |
Balance Sheet
The company has 114.69M in cash and 28.37M in debt, giving a net cash position of 86.32M.
| Cash & Cash Equivalents | 114.69M |
| Total Debt | 28.37M |
| Net Cash | 86.32M |
| Retained Earnings | -626.24M |
| Total Assets | 491.05M |
| Working Capital | 262.46M |
Cash Flow
In the last 12 months, operating cash flow was 38.05M and capital expenditures 0, giving a free cash flow of 31.56M.
| Operating Cash Flow | 38.05M |
| Capital Expenditures | 0 |
| Free Cash Flow | 31.56M |
| FCF Per Share | 0.6 |
Margins
Gross margin is 67.16%, with operating and profit margins of 12.21% and 15.74%.
| Gross Margin | 67.16% |
| Operating Margin | 12.21% |
| Pretax Margin | 15.84% |
| Profit Margin | 15.74% |
| EBITDA Margin | -10.18% |
| EBIT Margin | 12.21% |
| FCF Margin | 9.46% |
Dividends & Yields
CDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 4.65% |
| FCF Yield | 2.79% |
Analyst Forecast
The average price target for CDNA is $29, which is 92.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $29 |
| Price Target Difference | 92.6% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 5.23 |
| Piotroski F-Score | 5 |